3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
9
Lymphoma, Non-Hodgkin
7
Recurrence
2
Lymphoma
2
Cytokine Release Syndrome
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Solid Tumors
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Hodgkin Disease
1
Glioblastoma
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Craniopharyngioma
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Burkitt Lymphoma
1
Astrocytoma
1
Advanced Liver Cancers
1
Interventions
Cyclophosphamide
24
fludarabine
15
Rituximab
14
Specimen Handling
9
Magnetic Resonance Spectroscopy
8
Doxorubicin
7
pirtobrutinib
6
Vincristine
6
Prednisone
6
polatuzumab vedotin
5
obinutuzumab
5
Biopsy
5
zanubrutinib
4
glofitamab
4
Nivolumab
4
Etoposide
4
Dexamethasone
4
Bendamustine Hydrochloride
4
tazemetostat
3
tafasitamab
3
pembrolizumab
3
ibrutinib
3
fludarabine phosphate
3
acalabrutinib
3
Immunotherapy, Adoptive
3
venetoclax
2
pomalidomide
2
loncastuximab tesirine
2
etoposide phosphate
2
cemiplimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell
×
tocilizumab
×
90 days
×
Clear all
No trials found.